RUBINSTEIN OPENED THE 4TH LATIN AMERICAN POLICY FORUM EVALUATION HEALTH TECHNOLOGY
Government Secretary of Health of the Nation spoke against representatives
of companies and public and private health institutions in countries in the
region and stressed the importance of AGNET, agency assessment of medical
technology that drives the government. Monday 29 April 2019. Government
Secretary of Health, Adolfo Rubinstein, today inaugurated the 4th Latin
American Policy Forum Health Technology Assessment, organized by the Health
Technology Assessment International, which aims to promote a discussion
forum for professionals high-level strategic decision issues medical
technologies. The "Linkage between HTA and decision-making to prioritize
the allocation of health resources" Central -Topic the Forum- is considered
particularly important in countries seeking Universal Health Coverage and
was one of the aspects considered priority during the First Latin American
Forum. On that occasion, the principles of good practice were established
in the Health Technology Assessment in the region, highlighted by the
organization. "Argentina is at a key moment in what has to do with explicit
definitions of hedging policies through the creation of the National Agency
for Health Technology Assessment, which is one of the steps we are working
hard from the Ministry of Health along with other sectors including
industry, funders and providers and we hope that very soon see its
creation, "said Rubinstein front of representatives of 12 countries and 11
area businesses. "The support we have from HTAi, technicians, experts and
researchers in this area is essential for us to develop these initiatives
based on the best possible evidence and of course following the success and
mistakes to avoid repeating them and why this forum it is a learning space
which we can draw many lessons, "he added. Meanwhile, Hector Castro,
representative of HTAi, reflected on the emergence of the organization that
was created in 2003 and operates from Canada with 2,500 members and 82
organizations with partners from the academic community, government
officials, health professionals, and managers in the pharmaceutical sector
and stressed the importance of the annual conference this year will be in
Cologne.
of companies and public and private health institutions in countries in the
region and stressed the importance of AGNET, agency assessment of medical
technology that drives the government. Monday 29 April 2019. Government
Secretary of Health, Adolfo Rubinstein, today inaugurated the 4th Latin
American Policy Forum Health Technology Assessment, organized by the Health
Technology Assessment International, which aims to promote a discussion
forum for professionals high-level strategic decision issues medical
technologies. The "Linkage between HTA and decision-making to prioritize
the allocation of health resources" Central -Topic the Forum- is considered
particularly important in countries seeking Universal Health Coverage and
was one of the aspects considered priority during the First Latin American
Forum. On that occasion, the principles of good practice were established
in the Health Technology Assessment in the region, highlighted by the
organization. "Argentina is at a key moment in what has to do with explicit
definitions of hedging policies through the creation of the National Agency
for Health Technology Assessment, which is one of the steps we are working
hard from the Ministry of Health along with other sectors including
industry, funders and providers and we hope that very soon see its
creation, "said Rubinstein front of representatives of 12 countries and 11
area businesses. "The support we have from HTAi, technicians, experts and
researchers in this area is essential for us to develop these initiatives
based on the best possible evidence and of course following the success and
mistakes to avoid repeating them and why this forum it is a learning space
which we can draw many lessons, "he added. Meanwhile, Hector Castro,
representative of HTAi, reflected on the emergence of the organization that
was created in 2003 and operates from Canada with 2,500 members and 82
organizations with partners from the academic community, government
officials, health professionals, and managers in the pharmaceutical sector
and stressed the importance of the annual conference this year will be in
Cologne.